論文
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
Horm Cancer 3: 147-159, 2012
 Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S,
  Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S, 
  Maezono R, Kosai K, Takamatsu H.
  Therapeutic effects of vitamin A on experimental cholestatic rats with 
  hepatic fibrosis.
  Pediatr Surg Int. 27(8):863-70, 2011
 
Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.
Horm Cancer. 2: 286-297. 2011
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S.
Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.
J Steroid Biochem Mol Biol. 123: 1-7. 2011
 Kamisasanuki T, Wang Y, Tokushige S, Terasaki H, Khai NC, Wang Y,
  Kamisasanuki T, Wang Y, Tokushige S, Terasaki H, Khai NC, Wang Y, 
  Sakamoto T, Kosai K.
  Targeting CD9 produces stimulus-independent antiangiogenic effects 
  predominantly in activated endothelial cells during angiogenesis: A novel 
  antiangiogenic therapy.
Biochem. Biophys. Res. Commun. 16;413(1):128-35, 2011
 Horikawa Y, Wang Y, Nagano S, Kamizono J, Ikeda M, Komiya S, Kosai K.
 Horikawa Y, Wang Y, Nagano S, Kamizono J, Ikeda M, Komiya S, Kosai K.
 Assessment of an altered E1B promoter on the specificity and potency of 
 triple-regulated conditionally replicating adenoviruses (CRA) ⎯Implications 
 for the generation of ideal m-CRAs.
 Cancer Gene Ther 18(10):724-33, 2011
 Khai NC, Sakamoto K, Takamatsu H, Matsufuji H, Kosai K.
 Khai NC, Sakamoto K, Takamatsu H, Matsufuji H, Kosai K.
 Recombinant soluble form of HB-EGF protein therapy drastically 
 inhibits Fas-mediated fulminant hepatic failure: Implications in clinical 
 application.
 Hepatol Res. 41:594-596, 2011.
 

 Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S, 
  Maezono R, Kosai K, Takamatsu H.
  Therapeutic effects of vitamin A on experimental cholestatic rats with 
  hepatic fibrosis.
  Pediatr Surg Int. 27(8):863-70, 2011. 
 
Fujimura T, Takahashi S, Urano T, Ijichi N, Ikeda K, Kumagai J, Murata T, Takayama K, Horie-Inoue K, Ouchi Y, Muramatsu M, Homma Y, Inoue S.
Differential expression of estrogen-related receptors β and γ (ERRβ and ERRγ) and their clinical significance in human prostate cancer.
Cancer Sci. 101: 646-651, 2010
























